Latest Sabin Vaccine Institute Stories
Research funded by the Dengue Vaccine Initiative (DVI) involving an economic analysis of producing a tetravalent dengue vaccine shows that the cost could be as low as $0.20 per dose with an annual production level of 60 million doses packaged in ten-dose vials.
Researchers at Baylor College of Medicine will receive up to $6.2 million over five years from the National Institute Of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a vaccine for severe acute respiratory syndrome, commonly called SARS.
The open-access journal PLoS Neglected Tropical Diseases will publish an article emphasizing the rising burden of Neglected Tropical Diseases (NTDs) in Central Asia on Tuesday, Sept. 27th.
WASHINGTON, July 14, 2011 /PRNewswire-USNewswire/ -- The Sabin Vaccine Institute (Sabin) is pleased to announce the election of Baroness Helene Hayman, Gary Rosenthal, Marc Shapiro, and Alisa Swidler to the organization's Board of Trustees.